UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Dela ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 Earnings Conference Call November 2, 2021 8:30 AM ET Company Participants Jay Mazelsky – President and Chief Executive Officer John Ravis – Senior Director Investor Relations Brian Mc Keon – Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Nathan Rich – Goldman Sachs Jon Block – Stifel Chris Scott – JPMorgan Mitch – William Blair Balaji Prasad – Barclays Operator Good morning, and welcome to the IDEXX Laboratories Third Quarter 2 ...

Start Time: 08:30 January 1, 0000 9:30 AM ET IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2021 Earnings Conference Call July 30, 2021, 08:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - EVP, CFO and Treasurer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Jon Block - Stifel Nathan Rich - Goldman Sachs Operator Good morning and welcome to the IDEXX Laboratories Second Quarter 2021 Earnings Conference Call. As a reminder, today’s conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2021 Earnings Conference Call May 4, 2021 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Jon Block - Stifel Nathan Rich - Goldman Sachs Balaji Prasad - Barclays Operator Good morning and welcome to the IDEXX Laboratories' First Quarter 2021 Earnings Conference Call. As a reminder, today’s conference is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 0-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State or other ju ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2020 Earnings Conference Call February 2, 2021 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President & Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Nathan Rich - Goldman Sachs Jon Block - Stifel Chris Schott - JPMorgan Operator Good morning and welcome to the IDEXX Laboratories' Fourth Quarter 2020 Earnings Conference Call. As a reminder, today’s conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Dela ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2020 Earnings Conference Call October 29, 2020 8:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - CFO John Ravis - Senior Director, IR Conference Call Participants Ryan Daniels - William Blair Erin Wright - Credit Suisse Michael Ryskin - Bank of America Jon Block - Stifel Nathan Rich - Goldman Sachs David Westenberg - Guggenheim Securities Operator Good Morning, and welcome to the IDEXX Laboratories Third Quarter 2020 Earnings Call. As a ...